Evidence map›Paper›PMID 40450058›Full record

ArticleScientific reports2025

Atmospheric pressure plasma treatment increases the antioxidant capacity of the serum in vitro.

Yuqi Guo, Xi Zhang, Yanan Xing, Yuxuan Liu, Yixiao Liu, Liuya Jia, Lixin Xu, Gaosheng He, Jiting Ouyang, Xu Yan

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yuqi Guo *Department of Pathophysiology, Beijing Neurosurgical Institute/Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, People's Republic of China.
Xi Zhang *Department of Pathophysiology, Beijing Neurosurgical Institute/Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, People's Republic of China.
Yanan Xing *School of Physics, Beijing Institute of Technology, Beijing, 100081, People's Republic of China.
Yuxuan LiuSchool of Physics, Beijing Institute of Technology, Beijing, 100081, People's Republic of China.
Yixiao LiuDepartment of Pathophysiology, Beijing Neurosurgical Institute/Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, People's Republic of China.
Liuya JiaDepartment of Pathophysiology, Beijing Neurosurgical Institute/Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, People's Republic of China.
Lixin XuDepartment of Pathophysiology, Beijing Neurosurgical Institute/Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, People's Republic of China.
Gaosheng HeSchool of Physics, Beijing Institute of Technology, Beijing, 100081, People's Republic of China.
Jiting OuyangSchool of Physics, Beijing Institute of Technology, Beijing, 100081, People's Republic of China. jtouyang@bit.edu.cn.
Xu YanDepartment of Pathophysiology, Beijing Neurosurgical Institute/Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, People's Republic of China. devil-yx@163.com.

Funding

Xu Yan 52077006
6 · The paper itself

Abstract

The interaction of atmospheric pressure plasma (APP) with the liquids has been fully studied, and multiple biomedical applications of APP-activated liquids have also been verified. However, there is still no direct evidence regarding the interaction between APP treatment and serum. In the present study, the rat serum was treated with the helium APP device. Compared with APP-treated saline, the elevation of reactive oxygen species (ROS) levels in serum was significantly smaller, implying that an antioxidant system existed in serum. The proteomics suggested that differently expressed proteins were predominantly enriched in the glutathione metabolism pathway. Our results showed that APP treatment significantly increased the serum GSH level and GSH/GSSG ratio, suggesting the enhanced antioxidant capacity of the APP-treated serum. Furthermore, the antioxidant enzymes in APP-treated serum were examined. As a result, both the glutathione peroxidase (GPX) protein level and enzyme activity were up-regulated according to the parallel reaction monitoring (PRM) analysis and GPX enzyme activity analysis. Meanwhile, the activities of glutathione reductase (GR) and superoxide dismutase (SOD) enzymes were also enhanced after APP treatment, while the catalase (CAT) activity decreased. Meanwhile, the total antioxidant capacity (T-AOC) also increased, as confirmed by the evidence of the superior ROS scavenging by APP-treated serum. Our data highlight that APP treatment can enhance the antioxidant capacity of the serum, which is closely related to the up-regulated GSH level, GSH/GSSG ratio and antioxidant enzymes within serum after APP treatment.

Indexed as

AntioxidantsPlasma GasesSerumAnimalsAtmospheric PressureCatalaseGlutathioneGlutathione PeroxidaseGlutathione ReductaseMaleProteomicsRatsReactive Oxygen SpeciesSuperoxide DismutaseAntioxidantsCatalaseGlutathioneGlutathione PeroxidaseGlutathione ReductasePlasma GasesReactive Oxygen SpeciesSuperoxide DismutaseAntioxidant capacityAtmospheric pressure plasmaPlasma medicineReactive speciesSerum

Identifiers

PMID40450058
PMCPMC12126499

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.